90-Count Xarelto Lawsuit Requests $4.35 Million In Compensation For Alleged Bleeding Events

January 08, 2016 – – BloodThinnerHelp.com reports on a Madison County lawsuit which was filed against Xarelto manufacturers Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson). The suit alleges that the blood thinner, which is meant to prevent strokes, caused the plaintiff’s uncontrollable bleeding episode. After its initial filing, the case was moved during a Xarelto lawsuit consolidation. It was filed as a part of multidistrict litigation (MDL No. 2592) in the Eastern District of Louisiana and is being presided over by the Honorable Judge Eldon E. Fallon.

This particular case is a 90-count one, which seeks 4.35 million dollars in compensation. In details of the complaint, the plaintiff notes that defendants misleadingly marketed Xarelto as a safe and effective treatment for individuals who wish to reduce their risk of systemic embolism or stroke. The drug was approved for this use by the U.S. Food and Drug Administration, and was released for sale across the United States in 2011.

According to the plaintiff, manufacturers quickly became aware that bleeding from multiple areas of the body was reportedly increased for those taking the medication, yet, she claims, they did nothing with this knowledge. Her complaint notes: “Defendants use the results of the Rocket AF study, the Record studies, and the Einstein studies to promote Xarelto in their promotional materials, including the Xarelto website, which tout the positive results of those studies. However, defendants’ promotional materials fail to similarly highlight the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”

It was alleged that manufacturers spent over $11 million to promote their anticoagulant, which brought them around $582 million in sales the first year, according to the plaintiff. She states that they were misleading by purposefully emphasizing the effectiveness and benefits of the blood thinner, while concealing its dangerous potential side effects.

Unfortunately, the woman is not alone in her claims. Federal court has now reportedly consolidated more than 2,800 lawsuits filed against the drug in the Eastern Louisiana multidistrict litigation group. Additionally, another 500 Xarelto lawsuits have formed a mass tort litigation group in Philadelphia, Pennsylvania’s Court of Common Pleas.

Today, Attorney Joseph Osborne is attempting to ensure that everyone who has used Xarelto and has since suffered from adverse health events may have the opportunity to investigate their legal rights. It is likely that additional cases will be able to join the current MDL as these cases await trial. Attorney Osborne is offering free Xarelto consultations for affected individuals, who may be entitled to compensation.

To ask questions or request additional Xarelto lawsuit information, please contact Attorney Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60007049